The SUMOylation inhibitor subasumstat potentiates rituximab activity by IFN1-dependent macrophage and NK cell stimulation
Akito Nakamura, Dennis Huszar(Millennium Engineering and Integration (United States))
Cited by 69
Related Papers
A small-molecule SUMOylation inhibitor activates antitumor immune responses and potentiates immune therapies in preclinical models
|Science Translational Medicine|2021|139